跳至主要内容
临床试验/JPRN-UMIN000000744
JPRN-UMIN000000744未知1 期

Combination chemotherapy with docetaxel, cisplatine, and 5-fluorouracil for patients with advanced head and neck cancer: a phase I/II trial - TPF chemotherapy for advanced head and neck cancer: a phase I/II trial

Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Yamanashi0 个研究点目标入组 53 人开始时间: 2007年6月21日最近更新:
适应症

试验速览

阶段
1 期
发起方
入组人数
53

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Active multiple cancers. (only as for the phase I period) 2) Active infection disease with fever. 3) Serious complications (such as, heart failure, pulmonary fibrosis, interstitial pneumonia, and hemorrhagic tendency). 4) Metastasis to brain. 5) Pleural effusion or ascites requiring continuous drainage. 6) Pericardial effusion requiring treatment. 7) Edema grade 2 or more. 8) Previous history of severe drug hypersensitivity. 9) The patient who is pregnant, lactating, and potentially pregnant or hopes to become pregnant. 10) Long-term use of steroids. 11) The patient who has been judged to be ineligible for participating in this study by the attending physician.

研究者

发起方
Department of Otorhinolaryngology, Head and Neck Surgery, Faculty of Medicine, University of Yamanashi

相似试验